This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Investigation

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • urine testing
    • a urine dipstick test should be undertaken in all women presenting with urinary incontinence (UI) to detect the presence of blood, glucose, protein, leucocytes and nitrites in the urine
    • women with symptoms of urinary tract infection (UTI) whose urine tests positive for both leucocytes and nitrites should have a midstream urine specimen sent for culture and analysis of antibiotic sensitivities. An appropriate course of antibiotic treatment should be prescribed pending culture results
    • women with symptoms of UTI whose urine tests negative for either leucocytes or nitrites should have a midstream urine specimen sent for culture and analysis of antibiotic sensitivities. The healthcare professional should consider the prescription of antibiotics pending culture results
    • women who do not have symptoms of UTI, but whose urine tests positive for both leucocytes and nitrites, should not be offered antibiotics without the results of midstream urine culture
    • women who do not have symptoms of UTI and whose urine tests negative for either leucocytes or nitrites are unlikely to have UTI and should not have a urine sample sent for culture

  • assessment of residual urine
    • measurement of post-void residual volume by bladder scan or catheterisation should be performed in women with symptoms suggestive of voiding dysfunction or recurrent UTI. A bladder scan should be used in preference to catheterisation on the grounds of acceptability and lower incidence of adverse events
    • women who are found to have a palpable bladder on bimanual or abdominal examination after voiding should be referred to a specialist

  • bladder diaries
    • Bladder diaries should be used in the initial assessment of women with UI or OAB. Women should be encouraged to complete a minimum of 3 days of the diary covering variations in their usual activities, such as both working and leisure days

  • urodynamic testing
    • do not perform multichannel filling and voiding cystometry before primary surgery if stress urinary incontinence or stress-predominant mixed urinary incontinence is diagnosed based on a detailed clinical history and demonstrated stress urinary incontinence at examination

    • after undertaking a detailed clinical history and examination, perform multichannel filling and voiding cystometry before surgery for stress urinary incontinence in women who have any of the following:
      • urge-predominant mixed urinary incontinence or urinary incontinence in which the type is unclear
      • symptoms suggestive of voiding dysfunction
      • anterior or apical prolapse
      • a history of previous surgery for stress urinary incontinence


  • do not use imaging (MRI, CT, X-ray) for the routine assessment of women with urinary incontinence
    • ultrasound is not recommended other than for the assessment of residual urine volume
  • consider investigating the following symptoms in women with pelvic organ prolapse:
    • urinary symptoms that are bothersome and for which surgical intervention is an option
    • symptoms of obstructed defaecation or faecal incontinence
    • pain
    • symptoms that are not explained by examination findings

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.